XSHG
600195
Market cap1.01bUSD
Oct 09, Last price
6.73CNY
1D
1.36%
1Q
10.51%
Jan 2017
-25.55%
Name
China Animal Husbandry Industry Co Ltd
Chart & performance
P/E
40.11
P/S
1.11
EPS
0.17
Div yield, %
0.35%
Shrs. gr., 5y
0.15%
Rev. gr., 5y
4.42%
Revenues
6.20b
+3.11%
Net income
171m
+141.68%
CFO
1.16b
+175.89%
Dividend
Jul 07, 20260.051 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Animal Husbandry Industry Co., Ltd. operates within China, specializing in the development, manufacturing, and sale of products designed for animal health and nutrition. Its comprehensive range includes veterinary pharmaceuticals, vaccines, and other biological remedies for animals, as well as various feed products and nutritional additives. The company also engages in the trading of raw materials. Established in 1998, its corporate headquarters are situated in Beijing, China.
Key people
Dongxun Wu
Chairman of the Board · since 2025
Xinyan Zhang
Finance Director, Chief Accounting Officer · since 2024
Jie Jiao
Deputy General Manager, Secretary of the Board · since 2025
Shuihua Wang
Deputy General Manager · since 2017
Chunlin Xu
Deputy General Manager · since 2025
Yin Li
General Manager, Director · since 2024
Hemin Xu
Staff Elected Director · since 2025
Wenfeng Zong
Director · since 2025
Yan Hu
Independent Director · since 2024
Shiyan Qiao
Independent Director · since 2021
Gongyuan Tang
Independent Director · since 2020
Headquarters & legal address
北京市丰台区南四环西路188号八区16-19号楼
丰台区, BJ 100000
CN
丰台区, BJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||